Heung Bae Jeon

Title: Heung Bae Jeon: Innovator in Vitamin D Analog Development

Introduction

Heung Bae Jeon is a prominent inventor based in Andover, MA, USA, known for her significant contributions to the field of biochemistry and pharmacology. With two patents to her name, her work focuses on developing novel compounds that enhance the therapeutic applications of vitamin D.

Latest Patents

Heung Bae Jeon's latest patents encompass innovative D-ring and side-chain analogs of 1α,25-dihydroxyvitamin D. The first patent presents compositions comprising these compounds and methods that utilize them as selective inhibitors of CYP24, offering potential treatments for cell-proliferative disorders through modulation of vitamin D levels. The second patent introduces low-calcemic oxime analogs of 1α,25-dihydroxy vitamin D3, specifically 16-ene-C25-oxime and 16-ene-C-25-oxime ether analogs, which also serve as inhibitors of CYP24. Both patents highlight her commitment to addressing diseases that can benefit from the modulation of vitamin D levels.

Career Highlights

Heung Bae Jeon has worked with reputable organizations such as Cytochroma Inc. and The Johns Hopkins University. Her career has been marked by a focus on research and development in vitamin D analogs, positioning her as a notable figure in the advancement of therapeutic innovations in this area.

Collaborations

Throughout her career, Heung Bae Jeon has collaborated with esteemed colleagues, including Gary H. Posner and Jay A. White. These collaborations have enabled her to strengthen her research and contribute to significant advancements in vitamin D-related therapies.

Conclusion

Heung Bae Jeon's innovative work in the development of vitamin D analogs has paved the way for promising treatments of various disorders. Her patents reflect a dedication to advancing medical science, and her collaborations further emphasize the importance of teamwork in achieving groundbreaking innovations.